Establishment of 9L/F344 rat intracerebral glioma model of brain tumor stem cells

Zong-yu XIAO, Xiao-juan CHEN, Ru-xiang XU

Abstract


Objective To establish the 9L/F344 rat intracerebral glioma model of brain tumor stem cells.  Methods Rat 9L gliosarcoma stem-like cells were cultured in serum-free suspension. The expression of CD133 and nestin were tested by immunohistochemistry. A total of 48 inbredline male F344 rats were randomly divided into 2 groups, and 9L tumor sphere cells and 9L monolayer cells were respectively implanted into the right caudate nucleus of F344 rats in 2 groups. Survival time was observed and determined using the method of Kaplan-Meier survival analysis. Fourteen days after implantation or when the rats were dying, their brains were perfused and sectioned for HE staining, and CD133 and nestin were detected by immunohistochemistry.  Results Rat 9L tumor spheres were formed with suspension culture in serum-free medium. The gliomas formed in both groups were invasive without obvious capsule. More new vessels, bleeding and necrosis could be detected in 9L tumor spheres group. The tumor cells in both groups were positive for CD133 and nestin. There was no significant difference in the expression of CD133 and nestin between 2 groups (P > 0.05, for all). According to the expression of nestin, the tumors formed by 9L tumor sphere cells were more invasive. The median survival time of the rats bearing 9L tumor sphere cells was 15 d (95%CI: 15.219-15.781), and the median survival time of the rats bearing 9L monolayer cells was 21 d (95%CI: 20.395-21.605). There was significant difference between 2 groups (χ2 = 12.800, P = 0.000).  Conclusions 9L/F344 rat intracerebral glioma model of brain tumor stem cells is successfully established, which provides a glioma model for the future research.

 

DOI: 10.3969/j.issn.1672-6731.2015.04.012


Keywords


Glioma; Neoplastic stem cells; Immunohistochemistry; Cells, cultured; Disease models, animal

Full Text: PDF

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.